doi: 10.1200/JCO.2003.99.089.
Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer
- PMID: 12743164
- DOI: 10.1200/JCO.2003.99.089
Item in Clipboard
Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer
J Clin Oncol.
.
No abstract available
Similar articles
-
Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis.Breast. 2013 Aug;22 Suppl 2:S57-65. doi: 10.1016/j.breast.2013.07.011. Breast. 2013. PMID: 24074794 Review.
-
Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.Crit Rev Oncol Hematol. 2008 Jun;66(3):237-47. doi: 10.1016/j.critrevonc.2007.12.003. Epub 2008 Feb 1. Crit Rev Oncol Hematol. 2008. PMID: 18243010
-
Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics.J Clin Oncol. 2009 Sep 1;27(25):4103-8. doi: 10.1200/JCO.2008.21.0807. Epub 2009 Jul 27. J Clin Oncol. 2009. PMID: 19636014
-
Treatment decisions in metastatic colorectal cancer - Beyond first and second line combination therapies.Cancer Treat Rev. 2017 Sep;59:54-60. doi: 10.1016/j.ctrv.2017.04.007. Epub 2017 May 4. Cancer Treat Rev. 2017. PMID: 28738235 Review.
-
Analysis of tumor burden versus progression-free survival for Phase II decision making.Contemp Clin Trials. 2011 May;32(3):446-52. doi: 10.1016/j.cct.2011.01.010. Epub 2011 Jan 23. Contemp Clin Trials. 2011. PMID: 21266203
Cited by
-
Evolving options for the treatment of metastatic breast cancer: progression-free survival as an endpoint.Cancer Treat Rev. 2011 Nov;37(7):495-504. doi: 10.1016/j.ctrv.2011.01.002. Epub 2011 Feb 10. Cancer Treat Rev. 2011. PMID: 21315516 Free PMC article. Review.
-
Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials.Br J Cancer. 2006 Jun 19;94(12):1789-96. doi: 10.1038/sj.bjc.6603194. Epub 2006 May 30. Br J Cancer. 2006. PMID: 16736002 Free PMC article.
-
Chemotherapy before or after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer: 5-year results of the CAO/ARO/AIO-12 trial - a general pairwise comparison.ESMO Open. 2025 Mar;10(3):104483. doi: 10.1016/j.esmoop.2025.104483. Epub 2025 Mar 7. ESMO Open. 2025. PMID: 40056849 Free PMC article. Clinical Trial.
-
Contributions of meta-analyses based on individual patient data to therapeutic progress in colorectal cancer.Int J Clin Oncol. 2009 Apr;14(2):95-101. doi: 10.1007/s10147-009-0879-2. Epub 2009 Apr 24. Int J Clin Oncol. 2009. PMID: 19390939 Review.
-
Trends in endpoint selection in clinical trials of advanced breast cancer.J Cancer Res Clin Oncol. 2016 Nov;142(11):2403-13. doi: 10.1007/s00432-016-2221-5. Epub 2016 Sep 1. J Cancer Res Clin Oncol. 2016. PMID: 27586374 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
